Article
Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas.
Blood - 6 Jan 2022
Shen Yajie, Zhou Jingqi, Nie Kui, Cheng Shuhua, Chen Zhengming, Wang Wenhan, Wei Weiqing, Jiang Daiji, Peng Zijing, Ren Yizhuo, Zhang Yirong, Fan Qiuju, Richards Kristy L, Qi Yitao, Cheng Jinke, Tam Wayne, Ma Jiao
Abstract excerpt
Although oncogenicity of the stem cell regulator SOX9 has been implicated in many solid tumors, its role in lymphomagenesis remains largely unknown. In this study, SOX9 was overexpressed preferentially in a subset of diffuse large B-cell lymphomas (DLBCLs) that harbor IGH-BCL2 translocations. SOX9 positivity in DLBCL correlated with an advanced stage of disease. Silencing of SOX9 decreased cell proliferation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
